NF-κB in biology and targeted therapy: new insights and translational implications
NF-κB в биологии и таргетной терапии: новые представления и трансляционные перспективы
2024-03-03
SCID: 54.1/taztjpjx
Discuss with AI
IKK inhibitorsNF-κB signalinginflammatory responsestargeted therapytumor microenvironment
Figures from the paper
Abstract (AI)
NF-κB signaling has been discovered for nearly 40 years. Initially, NF-κB signaling was identified as a pivotal pathway in mediating inflammatory responses. However, with extensive and in-depth investigations, researchers have discovered that its role can be expanded to a variety of signaling mechanisms, biological processes, human diseases, and treatment options. In this review, we first scrutinize the research process of NF-κB signaling, and summarize the composition, activation, and regulatory mechanism of NF-κB signaling. We investigate the interaction of NF-κB signaling with other important pathways, including PI3K/AKT, MAPK, JAK-STAT, TGF-β, Wnt, Notch, Hedgehog, and TLR signaling. The physiological and pathological states of NF-κB signaling, as well as its intricate involvement in inflammation, immune regulation, and tumor microenvironment, are also explicated. Additionally, we illustrate how NF-κB signaling is involved in a variety of human diseases, including cancers, inflammatory and autoimmune diseases, cardiovascular diseases, metabolic diseases, neurological diseases, and COVID-19. Further, we discuss the therapeutic approaches targeting NF-κB signaling, including IKK inhibitors, monoclonal antibodies, proteasome inhibitors, nuclear translocation inhibitors, DNA binding inhibitors, TKIs, non-coding RNAs, immunotherapy, and CAR-T. Finally, we provide an outlook for research in the field of NF-κB signaling. We hope to present a stereoscopic, comprehensive NF-κB signaling that will inform future research and clinical practice.
Key Findings
1
Dysregulated NF-κB signaling contributes to cancers, inflammatory and autoimmune disorders, cardiovascular and metabolic diseases, neurological diseases, and COVID-19.
2
NF-κB has complex physiological and pathological roles in inflammation, immune regulation, and the tumor microenvironment.
3
NF-κB interacts extensively with PI3K/AKT, MAPK, JAK-STAT, TGF-β, Wnt, Notch, Hedgehog, and TLR pathways.
4
NF-κB signaling extends beyond inflammatory responses to regulate diverse signaling mechanisms, biological processes, and human diseases.
5
Therapeutic strategies targeting NF-κB include IKK inhibitors, monoclonal antibodies, proteasome and nuclear-translocation inhibitors, DNA-binding inhibitors, TKIs, non-coding RNAs, immunotherapy, and CAR-T approaches.
Research Object
NF-κB signaling in biological and disease contexts
Research Subject
The composition, activation, regulatory mechanisms, pathway interactions, biological and pathological roles, disease involvement, and therapeutic targeting of NF-κB signaling
Publication Details
Publication Date
2024-03-03
Journal
Publisher
ISSN
Cited by
2084
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai6
Cancer statistics, 20232023
Hallmarks of Cancer: New Dimensions2022
Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities2022
Targeting PI3K/Akt signal transduction for cancer therapy2021
Osteoarthritis: pathogenic signaling pathways and therapeutic targets2023
Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein–protein interaction module2016